Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.
ACS Chem Biol. 2023 Apr 21;18(4):693-700. doi: 10.1021/acschembio.1c00840. Epub 2022 Jan 19.
Acetylation at the α-N-terminus (Nα) is the most abundant modification detected on histone H4 and H2A, which is catalyzed by N-terminal acetyltransferase D (NatD or NAA40). Histone H4 and H2A contain an identical N-terminal SGRGK sequence that is enriched with post-translational modifications (PTMs) and frequently occurred oncogenic mutations known as "oncohistone" mutations. However, there is a lack of information on how oncohistone mutations and other PTMs affect NatD-catalyzed acetylation. Herein, we determined how the local chemical environment on the N-terminal SGRGK sequence impacts NatD-catalyzed Nα-acetylation on histone H4/H2A. Our studies indicate that all oncohistone mutations at SGRG suppressed NatD-catalyzed acetylation. Meanwhile, H4 Ser1 phosphorylation and Arg3 methylation negatively impact the NatD-mediated acetylation, but the Lys5 acetylation only has a marginal effect. This work reveals the impacts of oncohistone mutations on NatD activity and unravels the crosstalk between NatD and PTMs, implying potential regulatory mechanism of NatD and highlighting different avenues to interrogate the NatD-mediated pathway in the future.
Nα 端乙酰化是组蛋白 H4 和 H2A 上检测到的最丰富的修饰,由 N 端乙酰转移酶 D(NatD 或 NAA40)催化。组蛋白 H4 和 H2A 含有相同的 N 端 SGRGK 序列,富含翻译后修饰(PTM)和频繁发生的致癌突变,称为“癌组蛋白”突变。然而,关于癌组蛋白突变和其他 PTM 如何影响 NatD 催化的乙酰化的信息还很缺乏。本文我们确定了 N 端 SGRGK 序列上的局部化学环境如何影响 NatD 催化的组蛋白 H4/H2A 的 Nα-乙酰化。我们的研究表明,SGRG 上的所有癌组蛋白突变都抑制了 NatD 催化的乙酰化。同时,H4 Ser1 磷酸化和 Arg3 甲基化负向影响 NatD 介导的乙酰化,但 Lys5 乙酰化只有微小的影响。这项工作揭示了癌组蛋白突变对 NatD 活性的影响,并揭示了 NatD 和 PTM 之间的串扰,暗示了 NatD 的潜在调节机制,并突出了未来研究 NatD 介导途径的不同途径。